Shares of Portola Pharmaceuticals Inc. (NASDAQ:PTLA) have received a consensus rating of “Buy” from the seven research firms that are currently covering the firm. Two investment analysts have rated the stock with a hold recommendation and five have given a buy recommendation to the company. The average twelve-month target price among brokers that have issued […]